Effect of tocilizumab on intensive care patients with Covid-19 pneumonia, a retrospective cohort study | Zendy

Mehtap Pehlivanlar Küçük | Zendy; Ahmet Oğuzhan Küçük | Zendy; Ayşegül Pehlivanlar | Zendy; Sevil Ayaydın Mürtezaoğlu | Zendy; Kadir Çoban | Zendy; Gamze Kılıç | Zendy; Olcay Ayçiçek | Zendy; Funda Öztuna | Zendy; Yılmaz Bülbül | Zendy; Tevfik Özlü | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effect of tocilizumab on intensive care patients with Covid-19 pneumonia, a retrospective cohort study

Author(s) -

Mehtap Pehlivanlar Küçük,

Ahmet Oğuzhan Küçük,

Ayşegül Pehlivanlar,

Sevil Ayaydın Mürtezaoğlu,

Kadir Çoban,

Gamze Kılıç,

Olcay Ayçiçek,

Funda Öztuna,

Yılmaz Bülbül,

Tevfik Özlü

Publication year - 2021

Publication title -

turkish journal of medical sciences

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.277

H-Index - 27

eISSN - 1303-6165

pISSN - 1300-0144

DOI - 10.3906/sag-2106-42

Subject(s) - medicine , tocilizumab , retrospective cohort study , pneumonia , covid-19 , intensive care , cohort , cohort study , intensive care medicine , emergency medicine , rheumatoid arthritis , disease , infectious disease (medical specialty)

In this study, the efficacy of an IL-6 antagonist, Tocilizumab, administered in the early period was studied in intensive care patients with COVID-19 pneumonia followed by hypoxic and systemic inflammation not receiving mechanical ventilation support.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research